Table 5

Levels of biomarkers of oxidative stress in patients with leukemia compared with healthy individuals

VariablesALL
(n=72)
Control
(n=72)
P valueAML
(n=37)
Control
(n=37)
P value
Mean±SDMean±SDMean±SDMean±SD
SOD (U/mL)40.47±15.4269.20±19.94 <0.001* 37.40±14.4568.95±20.75 <0.001*
GPx (U/L)42.05±13.1950.19±10.83 <0.001* 45.78±14.1249.58±10.38 0.039*
CAT (KU/L)167.18±30.26166.72±24.260.919165.59±28.89169.17±22.290.552
TAC (nmol/Fe2+)439.21±104.27676.29±166.25 <0.001* 447.21±111.99695.7±166.93 <0.001*
MDA (nmol/mL)1.37±0.331.11±0.51 <0.001* 1.32±0.331.11±0.51 0.041*
NO (nmol/mL)20.04±2.7617.13±1.72 <0.001* 19.78±2.8217.36±1.50 <0.001*
PC (nmol/mg protein)3.35±0.942.28±0.59 <0.001* 3.36±1.012.29±0.52 <0.001*
AChE (U/g Hb)5.68±1.806.89±1.22 <0.001* 5.99±1.926.91±0.98 0.011*
PON1 (U/L)58.01±20.9482.93±18.79 <0.001* 56.89±20.7484.67±21.26 <0.001*
  • MDA, PC, and NO levels increased significantly, and TAC, SOD, GPx, AChE, and PON1 decreased significantly in patient with leukemia than in healthy individuals (p<0.05). However, no significant change in CAT level was observed between the groups (p>0.05).

  • *P<0.05.

  • AChE, acetylcholinesterase; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CAT, catalase; GPx, glutathione peroxidase; MDA, malondialdehyde; NO, nitric oxide; PC, protein carbonyl; PON1, paraoxonase-1; SOD, superoxide dismutase; TAC, total antioxidant capacity.